Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 13, 2016 12:37 PM ET

Healthcare Equipment and Supplies

Company Overview of AxoGen, Inc.

Company Overview

AxoGen, Inc. operates as a medical technology company. It offers a portfolio of nerve repair solutions for various surgical peripheral nerve repair needs. The company’s surgical nerve repair solutions include Avance Nerve Graft, a proprietary processed nerve allograft for bridging severed nerves without the comorbidities associated with a nerve autograft surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce coaptation sites while preventing soft tissue attachments. It also offe...

13631 Progress Boulevard

Suite 400

Alachua, FL 32615

United States

84 Employees

Phone:

386-462-6800

Fax:

386-462-6801

Key Executives for AxoGen, Inc.

Chief Executive Officer, President and Director
Age: 53
Total Annual Compensation: $473.3K
Chief Financial Officer, General Counsel, Senior Vice President of Business Development and Director
Age: 53
Total Annual Compensation: $326.8K
Senior Vice President of Sales
Age: 57
Total Annual Compensation: $384.3K
Compensation as of Fiscal Year 2014.

AxoGen, Inc. Key Developments

AxoGen, Inc. Announces Resignation of John Harper as a Member of the Board of Directors, Effective as of December 31, 2015

AxoGen, Inc. announced that on December 11, 2015, John Harper delivered to notice of his resignation as a member of the Board of Directors of the company effective as of December 31, 2015.

Xogen, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015; Revises Earnings Guidance for the Full Year 2015

AxoGen, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2015. For the quarter, the company reported revenues of $8,153,675 against $4,671,340 a year ago. Loss from operations was $1,917,826 against $1,802,904 a year ago. Net loss was $2,978,858 against $3,238,174 a year ago. Loss Per basic and diluted share was $0.11 against $0.19 a year ago. For the nine months, the company reported revenues of $19,522,244 against $12,023,789 a year ago. Loss from operations was $6,614,799 against $7,091,791 a year ago. Net loss was $9,744,932 against $11,219,210 a year ago. Loss Per basic and diluted share was $0.39 against $0.64 a year ago. Net cash used for operating activities was $8,790,266 against $8,019,485 a year ago. Purchase of property and equipment was $353,093 against $342,875 a year ago. Acquisition of intangible assets was $92,184 against $39,454 a year ago. The company announced that based on the strong growth in the first nine months of 2015 and continued sales momentum in the third quarter, the company is raising its revenue guidance and now expects 2015 full year revenue to be greater than $26.5 million with annual gross margins in the high 70% range.

AxoGen, Inc. to Report Q3, 2015 Results on Nov 05, 2015

AxoGen, Inc. announced that they will report Q3, 2015 results After-Market on Nov 05, 2015

Similar Private Companies By Industry

Company Name Region
LifeSpex Corp. United States
NinePoint Medical, Inc. United States
World Healthcare Systems, Inc. United States
Pharmaworks Inc. United States
Teleflex Medical OEM United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AxoGen, Inc., please visit www.axogeninc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.